Romiplostim acts on which of the following receptors:
Romiplostim: Genetically engineered protein in which the Fc component of a human antibody is fused to two copies of a peptide that stimulates the thrombopoietin receptors; approved for treatment of idiopathic thrombocytopenic purpura Ref: Katzung 11th edition Chapter 33.
Thrombopoeitin
IL 6
IL 8
PGE 1